Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06170450 · ClinicalTrials.gov registry record · NA
Cyclic Versus Continuous Sacral Neuromodulation for LUTS
A NA study of Overactive Bladder Syndrome, sponsored by University Hospitals Cleveland Medical Center.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT06170450: Active NA study of Overactive Bladder Syndrome, sponsored by University Hospitals Cleveland Medical Center.
NCT06170450 is a NA study of Overactive Bladder Syndrome that is active but no longer recruiting, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 50 participants, below the 117-participant average among 11 other Overactive Bladder Syndrome trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06170450, a NA study of Overactive Bladder Syndrome, is active but no longer recruiting, sponsored by University Hospitals Cleveland Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
This will be a prospective, randomized-controlled multi-site trial comparing cyclic versus continuous sacral neuromodulation (SNM) for OAB.
Primary Outcome
ICIQ-OABqol is a 28 question patient-completed survey evaluating quality of life (QoL) in patients with overactive bladder. Score ranges 25-160 points with greater value indicating increased impact on quality of life.
Conditions Studied
Interventions
- DEVICE Cyclic SNM
- DEVICE Continuous SNM
Study Locations (3)
Ohio
- University Hospitals - Cleveland
- MetroHealth - Cleveland
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2030-06 |
| Phase | NA |
What the registry record for NCT06170450 still lists
NCT06170450 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 117-participant average among 11 other Overactive Bladder Syndrome trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Overactive Bladder Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Cyclic SNM is the first listed.
NCT06170450 reports a single indexed study location in Ohio, Kentucky.
Frequently Asked Questions
What is clinical trial NCT06170450 about?
NCT06170450 is a clinical study titled "Cyclic Versus Continuous Sacral Neuromodulation for LUTS". This will be a prospective, randomized-controlled multi-site trial comparing cyclic versus continuous sacral neuromodulation (SNM) for OAB.
What is the current status of trial NCT06170450?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-15. Estimated completion is 2030-06.
What conditions does trial NCT06170450 study?
This clinical trial studies the following conditions: Overactive Bladder Syndrome.
What interventions are being tested in trial NCT06170450?
The interventions under investigation include: Cyclic SNM (DEVICE), Continuous SNM (DEVICE).
Who is sponsoring clinical trial NCT06170450?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06170450 being conducted?
This trial has 3 study locations across Kentucky, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06170450's enrollment target sits among peer trials
50 8th of 11 higher than 3 of 11 other Overactive Bladder Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
RECRUITING · NA
-
Yoga for Treatment of Overactive Bladder in Pediatric Patients
RECRUITING · NA
-
rTMS in Overactive Bladder
RECRUITING · NA
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI